3,5-dimethyladamantan-1-ol,
3,5-Dimethyl-1-adamantanol,
707-37-9,
1-Hydroxy-3,5-dimethyladamantane,
1,3-Dimethyl-5-hydroxyadamantane,
LBWCITVBZLTEKW-UHFFFAOYSA-N,
Tricyclo[3.3.1.13,7]decan-1-ol, 3,5-dimethyl-,
NSC102294,
ACMC-209ofx,
AC1L6EQH,
1,3-dimethyl-5-adamantanol,
MeMantine Related CoMpound B,
SCHEMBL733948,
AC1Q79E1,
CTK5D2914,
DTXSID10295485,
1-hydroxy-3,5-dimethyl adamantane,
ALBB-013874,
KS-000000VC,
ZX-AN012623,
ANW-35947,
CD-937,
MFCD00074775,
STL420421,
AKOS001056991,
AKOS016313890,
AN-1119,
CS-W016006,
FCH1672740,
MCULE-1816289049,
NSC-102294,
QC-1269,
TRA0042139,
AC-14487,
AK129940,
AS-15103,
O036,
AB0016215,
AX8082772,
DB-003031,
TR-031032,
D3697,
FT-0667364,
R1961,
ST45024413,
A836978,
AE-641/01642003,
3,5-dimethyltricyclo[3.3.1.1~3,7~]decan-1-ol,
I14-9502,
Tricyclo[3.3.1.13,7]decan-1-ol,3,5-dimethyl-,
Z56852724,
tricyclo[3.3.1.1~3,7~]decan-1-ol, 3,5-dimethyl-,
1-hydroxy-,
3,5-dimethyladamantane,
1,3-DIMETHYLADAMANTANE,
C12H20O,
AR-1E9760,
CID265793,
ACN-053950,
1-Azabicyclo[2.2.2]octan-3-one hydrochloride,
71392-09-1,